Why COAs Matter
The integrity of preclinical research depends on well-characterized inputs. When peptide composition differs from supplier claims, experimental outcomes become unreliable and cross-laboratory reproducibility is impossible. A COA documents actual measured values from a specific production batch — not theoretical targets or manufacturer intentions. In the research chemical market, where no regulatory body independently certifies products before sale, the COA is the primary quality assurance document available to researchers.
Essential COA Components
A legitimate COA should include all of the following:
- Peptide name, sequence, and molecular formula
- Batch/lot number with manufacture and testing dates
- HPLC purity percentage with chromatogram images (area-under-curve method)
- Mass spectrometry data confirming observed vs. theoretical molecular weight
- Water content measurement (Karl Fischer titration preferred)
- Residual solvent measurements where applicable
- Analyst signatures and independent laboratory identification with contact information
- Testing methodology references (instrument models, column specifications for HPLC)
Absence of any of these components — particularly the batch number, chromatogram images, or laboratory identification — is a significant quality concern.
Reading HPLC Data
High-performance liquid chromatography (HPLC) measures purity by separating components in a sample and quantifying each by area under the absorption curve. The reported purity percentage represents the target peptide's area as a fraction of total detected area.
What to look for in an HPLC chromatogram: - A single dominant peak corresponding to the target peptide (high-purity material) - Minimal "satellite" peaks (impurities from incomplete reactions, deletion sequences, or oxidized variants) - The reported retention time should be consistent with the peptide's hydrophobicity and the stated column conditions - Area-under-curve integration method should be stated (not peak height method, which is less accurate)
Purity thresholds: - ≥98%: Industry minimum standard for research-grade peptides - ≥99%: Preferred for sensitive assays where trace impurities could confound results - <98%: Below standard; seek alternative supplier or request re-testing documentation - 95–97%: May be acceptable for pilot studies but not for publication-quality research
Note that HPLC purity measures what is detected by UV absorption at the set wavelength (typically 220 nm or 254 nm). It does not detect all possible contaminants — particularly those lacking UV absorption at the measurement wavelength. HPLC purity alone is insufficient without mass spectrometry identity confirmation.
Mass Spectrometry Interpretation
Mass spectrometry (MS) confirms the identity of the peptide by measuring its molecular weight. The observed mass should match the theoretical molecular weight calculated from the amino acid sequence within instrument accuracy.
Typical accuracy tolerances: - High-resolution instruments (QTOF, Orbitrap): ±0.005 Da or better - Standard instruments (single quadrupole): ±0.1–0.5 Da - MALDI-TOF: ±0.1–1 Da depending on calibration
What MS confirms: - Correct amino acid sequence is present (indirectly, via molecular weight match) - No truncation sequences or gross synthesis errors - Correct salt form mass (e.g., acetate vs. trifluoroacetate affects observed mass)
What MS cannot confirm: - Stereochemistry (L vs. D amino acids have identical mass) - Sequence order in peptides where permutations share identical molecular formulas - Impurities present at levels below the instrument's detection limit
For complex peptides with fatty acid modifications (semaglutide, tirzepatide, retatrutide, CJC-1295 DAC), mass confirmation is particularly important because the modification substantially increases molecular weight and synthesis complexity, making errors more likely.
Water Content and Residual Solvents
Water content (Karl Fischer titration): Lyophilized peptides retain some residual water; values of 5–12% water content are typical and acceptable. Very high water content (>15%) suggests incomplete lyophilization, which affects both the peptide's nominal mass and its long-term stability. Water content data allows accurate correction of stated peptide mass — a 5 mg vial with 10% water contains approximately 4.5 mg of dry peptide. Fill size is what that correction applies to, so for a 5 mg listing such as BPC-157 5mg it is the corrected dry mass, not the label figure, that should feed concentration calculations.
Residual solvents: HPLC-grade solvents used in peptide purification (acetonitrile, TFA, acetic acid, DMF) may persist in lyophilized product. ICH Q3C guidelines provide limits for residual solvents in pharmaceutical materials; research-grade peptides should ideally meet these limits, particularly for cell culture applications where solvent residues at trace concentrations can affect cell viability or assay signals.
Red Flags in COA Documentation
- Missing batch numbers (generic or recycled COAs)
- Vague methodology without instrument specifications
- Absent chromatogram images (purity number only, without visual data)
- Mismatched manufacture and test dates (test date before manufacture date)
- Identical COAs across different production batches (photocopied documents)
- Laboratory name not independently verifiable via web search or accreditation database
- COA issued by the supplier itself rather than an independent third-party laboratory
- Molecular weight listed as "theoretical" rather than "observed"
Verifying Independent Laboratory Credentials
Third-party testing removes the manufacturer's conflict of interest in reporting quality. To verify a referenced laboratory:
- Search the laboratory name to confirm it is a real, independently operating analytical laboratory
- Check for ISO 17025 accreditation (the international standard for testing laboratory competence)
- Confirm the laboratory's stated specialization includes peptide analysis (not all analytical labs have the columns and expertise for small molecule peptide HPLC)
- Contact the laboratory directly if significant quality concerns arise — legitimate labs can confirm testing was performed for a specific batch
Lux BioPure's quality assurance process uses third-party independent laboratory verification as the standard for all batches, with batch-specific COAs published in the product documentation. Compound-level HPLC and mass-spec results are also summarized in the independent purity report. Individual listings carry the same batch documentation alongside the product record — Semaglutide 10mg and Retatrutide 10mg show how a batch result is presented against the compound it was tested for.
Comparing COAs Across Suppliers
When evaluating multiple Canadian suppliers, COA documentation quality is a primary differentiator:
| Feature | Quality Supplier | Lower-Quality Supplier |
|---|---|---|
| HPLC chromatogram | Included with each batch | Absent or generic |
| MS confirmation | Observed mass reported | Theoretical only |
| Lab identity | Named, verifiable third party | Anonymous or internal |
| Batch specificity | Unique per production lot | Same document reused |
| Water content | Reported | Not measured |
| Purity threshold | ≥98–99% typical | ≥95% or unstated |
Frequently Asked Questions
What is a peptide Certificate of Analysis (COA)? A COA documents actual measured values from a specific production batch — not theoretical targets or manufacturer intentions. In the research chemical market, where no regulatory body independently certifies products before sale, the COA is the primary quality assurance document available to researchers for confirming identity, purity, and quality.
What should a legitimate peptide COA include? A legitimate COA includes the peptide name, sequence, and molecular formula; a batch number with manufacture and testing dates; HPLC purity percentage with chromatogram images; mass spectrometry data comparing observed and theoretical molecular weight; water content; analyst signatures; and independent laboratory identification. Missing batch numbers or chromatograms are quality concerns.
What HPLC purity threshold should research peptides meet? At least 98% is the industry minimum standard for research-grade peptides, with 99% preferred for sensitive assays where trace impurities could confound results. Below 98% is substandard. HPLC purity alone is insufficient, though, and must be paired with mass spectrometry identity confirmation.
How do I verify the testing laboratory named on a COA? Confirm the laboratory is a real, independently operating analytical lab, check for ISO 17025 accreditation, and confirm its specialization includes peptide analysis. A COA issued by the supplier itself rather than an independent third party is a red flag, as third-party testing removes the manufacturer's conflict of interest.
Research Disclaimer
COA evaluation guidance provided here is for research quality assurance purposes. All peptides described are for in vitro laboratory research use only and are not approved for human or veterinary therapeutic use by Health Canada or any regulatory authority.